Published in Nephrol Dial Transplant on January 01, 1993
Lipoprotein (a): impact by ethnicity and environmental and medical conditions. J Lipid Res (2015) 0.81
Serum lipoprotein(a) (Lpa(a)) in haemodialysis patients. Nephrol Dial Transplant (1994) 0.75
Three-dimensional structure of the beta subunit of E. coli DNA polymerase III holoenzyme: a sliding DNA clamp. Cell (1992) 5.77
Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell (1996) 5.38
UmuD'(2)C is an error-prone DNA polymerase, Escherichia coli pol V. Proc Natl Acad Sci U S A (1999) 4.24
The Zarit Burden Interview: a new short version and screening version. Gerontologist (2001) 3.95
Roles of E. coli DNA polymerases IV and V in lesion-targeted and untargeted SOS mutagenesis. Nature (2000) 3.95
Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients? Lancet (1993) 3.54
Mechanism of the sliding beta-clamp of DNA polymerase III holoenzyme. J Biol Chem (1991) 3.37
DNA polymerase III holoenzyme: structure and function of a chromosomal replicating machine. Annu Rev Biochem (1995) 3.27
Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA (1996) 3.14
Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci U S A (1994) 3.03
Speckle tracking methods for ultrasonic elasticity imaging using short-time correlation. IEEE Trans Ultrason Ferroelectr Freq Control (1999) 2.97
Crystal structure of the processivity clamp loader gamma (gamma) complex of E. coli DNA polymerase III. Cell (2001) 2.68
Some enzymic activities and chemical properties of the mesosomes and cytoplasmic membranes of Bacillus licheniformis 6346. Biochem J (1969) 2.56
Trading places on DNA--a three-point switch underlies primer handoff from primase to the replicative DNA polymerase. Cell (1999) 2.51
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med (2000) 2.48
Mechanism of processivity clamp opening by the delta subunit wrench of the clamp loader complex of E. coli DNA polymerase III. Cell (2001) 2.39
Biochemical basis of SOS-induced mutagenesis in Escherichia coli: reconstitution of in vitro lesion bypass dependent on the UmuD'2C mutagenic complex and RecA protein. Proc Natl Acad Sci U S A (1998) 2.22
Crystal structure of the delta' subunit of the clamp-loader complex of E. coli DNA polymerase III. Cell (1997) 2.16
Sliding clamps of DNA polymerases. J Mol Biol (1993) 2.11
Clamp loading, unloading and intrinsic stability of the PCNA, beta and gp45 sliding clamps of human, E. coli and T4 replicases. Genes Cells (1996) 2.09
Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism. Lancet (1979) 2.08
Hospital volume and stroke outcome: does it matter? Neurology (2007) 2.07
Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J Biol Chem (1991) 2.06
Activity of the purified mutagenesis proteins UmuC, UmuD', and RecA in replicative bypass of an abasic DNA lesion by DNA polymerase III. Proc Natl Acad Sci U S A (1992) 2.03
Crystal structure of the DNA polymerase processivity factor of T4 bacteriophage. J Mol Biol (2000) 2.02
Multiple competition reactions for RPA order the assembly of the DNA polymerase delta holoenzyme. EMBO J (1999) 2.00
Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00
Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol (2000) 1.99
The internal workings of a DNA polymerase clamp-loading machine. EMBO J (1999) 1.98
Devoted to the lagging strand-the subunit of DNA polymerase III holoenzyme contacts SSB to promote processive elongation and sliding clamp assembly. EMBO J (1998) 1.97
An explanation for lagging strand replication: polymerase hopping among DNA sliding clamps. Cell (1994) 1.94
Phase-aberration correction using signals from point reflectors and diffuse scatterers: basic principles. IEEE Trans Ultrason Ferroelectr Freq Control (1988) 1.90
Interaction of the beta sliding clamp with MutS, ligase, and DNA polymerase I. Proc Natl Acad Sci U S A (2001) 1.84
Normal values for peripheral blood white cell counts in women of four different ethnic origins. J Clin Pathol (1984) 1.84
Quantification of the degradation products of sevoflurane in two CO2 absorbants during low-flow anesthesia in surgical patients. Anesthesiology (1992) 1.84
An interaction between DNA ligase I and proliferating cell nuclear antigen: implications for Okazaki fragment synthesis and joining. Proc Natl Acad Sci U S A (1997) 1.82
Replisome assembly at oriC, the replication origin of E. coli, reveals an explanation for initiation sites outside an origin. Mol Cell (1999) 1.82
Structure of the peptidogylcan of bacterial cell walls. I. J Mol Biol (1977) 1.79
A molecular switch in a replication machine defined by an internal competition for protein rings. Cell (1996) 1.77
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet (2006) 1.76
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol (1992) 1.73
Processive DNA synthesis by DNA polymerase II mediated by DNA polymerase III accessory proteins. J Biol Chem (1992) 1.72
Fidelity of Escherichia coli DNA polymerase III holoenzyme. The effects of beta, gamma complex processivity proteins and epsilon proofreading exonuclease on nucleotide misincorporation efficiencies. J Biol Chem (1997) 1.70
Replisome assembly reveals the basis for asymmetric function in leading and lagging strand replication. Cell (1996) 1.68
Sliding clamps: a (tail)ored fit. Curr Biol (2000) 1.68
Dialysis arthropathy: complication of long term treatment with haemodialysis. Br Med J (Clin Res Ed) (1986) 1.67
Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A (1991) 1.66
Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med (1998) 1.65
A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet (1985) 1.64
ATP binding to the Escherichia coli clamp loader powers opening of the ring-shaped clamp of DNA polymerase III holoenzyme. J Biol Chem (1998) 1.63
Structural and functional similarities of prokaryotic and eukaryotic DNA polymerase sliding clamps. Nucleic Acids Res (1995) 1.62
Measuring the elastic modulus of small tissue samples. Ultrason Imaging (1998) 1.58
Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Atherosclerosis (1976) 1.58
Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation (2001) 1.55
Deletion analysis of the large subunit p140 in human replication factor C reveals regions required for complex formation and replication activities. J Biol Chem (1997) 1.55
Processive replication is contingent on the exonuclease subunit of DNA polymerase III holoenzyme. J Biol Chem (1990) 1.55
Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.54
Proline specific peptidases. Biochim Biophys Acta (1997) 1.54
Studies on the interactions between human replication factor C and human proliferating cell nuclear antigen. Proc Natl Acad Sci U S A (1999) 1.54
Selection and microevolution of coat pattern are cryptic in a wild population of sheep. Mol Ecol (2012) 1.53
Analysis of the ATPase subassembly which initiates processive DNA synthesis by DNA polymerase III holoenzyme. J Biol Chem (1991) 1.52
Compound A concentrations during sevoflurane anesthesia in children. Anesthesiology (1996) 1.52
Health status of children with moderate to severe cerebral palsy. Dev Med Child Neurol (2001) 1.51
Assembly of a chromosomal replication machine: two DNA polymerases, a clamp loader, and sliding clamps in one holoenzyme particle. I. Organization of the clamp loader. J Biol Chem (1995) 1.49
Battle of the clotbusters. BMJ (1991) 1.47
3-D correlation-based speckle tracking. Ultrason Imaging (2005) 1.46
Constitution of the twin polymerase of DNA polymerase III holoenzyme. J Biol Chem (1991) 1.45
A complex consisting of human replication factor C p40, p37, and p36 subunits is a DNA-dependent ATPase and an intermediate in the assembly of the holoenzyme. J Biol Chem (1997) 1.44
Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system. Br J Pharmacol (1986) 1.43
Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia. J Thromb Haemost (2007) 1.43
The influence of the proliferating cell nuclear antigen-interacting domain of p21(CIP1) on DNA synthesis catalyzed by the human and Saccharomyces cerevisiae polymerase delta holoenzymes. J Biol Chem (1997) 1.42
Squamous cell carcinoma of skin with a rhabdoid phenotype: a case report. J Clin Pathol (2000) 1.42
Indirect airway challenges. Eur Respir J (2003) 1.42
Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort. Atherosclerosis (1999) 1.41
Captopril renal scintigraphy in patients with hypertension and chronic renal failure. J Nucl Med (1994) 1.41
Continuous arteriovenous haemodialysis in critically ill patients. Lancet (1988) 1.41
Impact of new dialysis solutions on peritonitis rates. Kidney Int Suppl (2006) 1.41
A model for SOS-lesion-targeted mutations in Escherichia coli. Nature (2001) 1.41
CAPD, protective against developing dialysis-associated amyloid? Nephron (1988) 1.40
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA. J Virol (1993) 1.40
Errors in the measurements of T2 using multiple-echo MRI techniques. I. Effects of radiofrequency pulse imperfections. Magn Reson Med (1986) 1.39
Management issues for debate: the problems in perspective. Aliment Pharmacol Ther (1993) 1.39
Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant (1992) 1.39
Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone). Steroids (1972) 1.39
Relaxant activity of atriopeptins in isolated guinea pig airway and vascular smooth muscle. Peptides (1985) 1.39
DNA polymerase III accessory proteins. V. Theta encoded by holE. J Biol Chem (1993) 1.39
Dialysis-associated amyloid: systemic or local? Nephrol Dial Transplant (1989) 1.38
Should we protect families from patients? Hastings Cent Rep (1998) 1.38
Strain rate imaging using two-dimensional speckle tracking. IEEE Trans Ultrason Ferroelectr Freq Control (2001) 1.37
The isolation and characterisation of cytoplasmic membranes and mesosomes of Bacillus licheniformis 6346. Biochem Biophys Res Commun (1968) 1.35
A nonadrenergic vagal inhibitory pathway to feline airways. Science (1980) 1.35
EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin. J Virol (1992) 1.34
Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A (1989) 1.34
The cell walls of Pseudomonas aeruginosa. General composition. Biochem J (1967) 1.33
holE, the gene coding for the theta subunit of DNA polymerase III of Escherichia coli: characterization of a holE mutant and comparison with a dnaQ (epsilon-subunit) mutant. J Bacteriol (1994) 1.31
A TOPRIM domain in the crystal structure of the catalytic core of Escherichia coli primase confirms a structural link to DNA topoisomerases. J Mol Biol (2000) 1.30